CIITA gene polymorphism (rs3087456) in systemic lupus erythematosus and rheumatoid arthritis: A population‐based cohort study
- 27 June 2021
- journal article
- research article
- Published by Wiley in International Journal of Immunogenetics
- Vol. 48 (5) , 429-434
Abstract
Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are influenced by genetic variants in immune system HLA genes. The Class II Major Histocompatibility Complex Transactivator (CIITA) is an important co-activator of the HLA transcriptional complex; the single nucleotide variant (SNV) rs3087456 localized in the gene promoter region (−168 A/G) has been reported as able to modify its transcription level. In our study, we assessed CIITA rs3087456 SNV in 1,044 Brazilians from two Brazilian regions (Northeast and South) to verify the association with susceptibility and clinical manifestations of (SLE) and (RA) using TaqMan SNP Genotyping Assays System. We observed a protection for a recessive model (GG x AA+AG) for RA susceptibility and increased risk for erosion development in AG genotype patients. No significant association was observed for SLE susceptibility; however, we observed significant increased risk for Class IV and V nephritis development in G allele and GG genotype patients. In conclusion, we showed the contribution of CIITA rs3087456 to SLE or RA clinical features and RA susceptibility in the studied populations.Keywords
This publication has 29 references indexed in Scilit:
- The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than ExpectedPLOS ONE, 2011
- CIITA is not associated with risk of developing rheumatoid arthritisGenes & Immunity, 2011
- Lack of association of the CIITA-168A→G promoter SNP with myasthenia gravis and its role in autoimmunityBMC Medical Genetics, 2010
- CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosisHuman Molecular Genetics, 2010
- The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patientsRheumatology, 2010
- Developments in the scientific understanding of lupusArthritis Research & Therapy, 2008
- Protective effect of A at position –168 in the type III promoter of the MHCIITA gene in systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2007
- MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patientsRheumatology, 2007
- Up-regulated MHC-class II expression and γ-IFN and soluble IL-2R in lupus nephritisKidney International, 1992
- Selection of pairwise multiple comparison procedures for parametric and nonparametric analysis of variance models.Psychological Bulletin, 1984